US partners Michael Hinckle and Gina Bertolini and Tokyo Counsel Aiko Yamada co-authored a series of 4 articles which were first published by In-House Community that provide an overview of the predominant regulatory considerations non-US companies should know if they plan to develop or expand their digital health presence in the United States.
Download the articles:
- A Guide to US Regulations for Non-US Companies Seeking to Navigate the US Digital Health Market – Part I: HIPPA Overview
- A Guide to US Regulations for Non-US Companies Seeking to Navigate the US Digital Health Market – Part II: HIPPA (Continued) & Additional Important Privacy Considerations
- A Guide to US Regulations for Non-US Companies Seeking to Navigate the US Digital Health Market – Part III: FDCA
- A Guide to US Regulations for Non-US Companies Seeking to Navigate the US Digital Health Market – Part IV: Other Potential Applicable Laws
